SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-24-029952
Filing Date
2024-03-12
Accepted
2024-03-12 16:15:38
Documents
82
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K lbph-20231231.htm   iXBRL 10-K 2417597
2 EX-10.4 lbph-ex10_4.htm EX-10.4 314194
3 EX-10.6 lbph-ex10_6.htm EX-10.6 82780
4 EX-23.1 lbph-ex23_1.htm EX-23.1 2860
5 EX-31.1 lbph-ex31_1.htm EX-31.1 16472
6 EX-31.2 lbph-ex31_2.htm EX-31.2 16514
7 EX-32.1 lbph-ex32_1.htm EX-32.1 15701
8 EX-97.1 lbph-ex97_1.htm EX-97.1 51788
9 GRAPHIC img9543357_0.jpg GRAPHIC 90708
10 GRAPHIC img9543357_1.jpg GRAPHIC 95266
11 GRAPHIC img9543357_2.jpg GRAPHIC 156556
12 GRAPHIC img9543357_3.jpg GRAPHIC 54715
13 GRAPHIC img9543357_4.jpg GRAPHIC 83745
14 GRAPHIC img9543357_5.jpg GRAPHIC 74781
15 GRAPHIC img9543357_6.jpg GRAPHIC 88359
16 GRAPHIC img9543357_7.jpg GRAPHIC 52197
17 GRAPHIC img9543357_8.jpg GRAPHIC 90708
  Complete submission text file 0000950170-24-029952.txt   11180017

Data Files

Seq Description Document Type Size
18 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT lbph-20231231.xsd EX-101.SCH 1124186
84 EXTRACTED XBRL INSTANCE DOCUMENT lbph-20231231_htm.xml XML 1439741
Mailing Address 4275 EXECUTIVE SQUARE SUITE 950 LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE SUITE 950 LA JOLLA CA 92037 619-592-9775
Longboard Pharmaceuticals, Inc. (Filer) CIK: 0001832168 (see all company filings)

IRS No.: 845009619 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-40192 | Film No.: 24742259
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)